TQS Magazine on MSN

How AI is Transforming Mobile Apps in 2026: Trends and Innovations

Discover how Artificial Intelligence is transforming mobile app development in 2026 with trends like hyper-personalization, ...
BMJ Open Sport & Exercise Medicine

COVID-19 infection and return-to-play outcomes of elite athletes in Japan: a retrospective descriptive study

Objectives To describe the characteristics of COVID-19 among elite Japanese athletes and their return-to-play (RTP) ...

Ex-MP 'instrumental' in bogus Covid firm - court

Mr Malik, 57, is accused of running a fraudulent business and public nuisance alongside Dewsbury East councillor Paul Moore, ...
Northern Scot

Former Labour MP ran ‘shoddy and inadequate’ Covid-19 testing lab, trial told

Shahid Malik is one of five people accused of taking advantage of the Government’s need to scale up testing for the virus in ...

Here's How To Tell Regular Flu From Covid (According To A Doctor)

According to Dr Neel Patel from LloydsPharmacy Online Doctor, telling one apart form the other may be key as the cooler ...

ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease recurrence or death by 53% vs. T-DM1 in patients with high-risk HER2-positive early breast cancer ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery resulted in a pathologic complete response in 67% of patients with high-risk HER2-positive early ...

Positive results from the DESTINY-Breast11 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) followed by paclitaxel, trastuzumab and pertuzumab (THP) in the neoadjuvant setting ...